Of 12 published TCGA cohorts showing FOXP1-SHQ1 deletion and PTEN deletion individually in at least 2% of tumors, 7 cancer types showed significantly enriched co-deletion of the two regions (Fig. 1c, Supplementary Table 2). This evidence concerns the gene PTEN and cancer.